SMAD4 and cancer: Given the strong inflammatory phenotypes observed in epithelial Smad4‐deficient mice treated with DSS and the predisposing role of inflammation in cancer development,[32] we extended our investigation to determine whether Smad4 plays a role in inflammation‐associated intestinal tumorigenesis.